These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3047394)

  • 1. Transdermal scopolamine in drooling.
    Brodtkorb E; Wyzocka-Bakowska MM; Lillevold PE; Sandvik L; Saunte C; Hestnes A
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():233-7. PubMed ID: 3047394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of drooling with transdermal scopolamine in a child with cerebral palsy.
    Siegel LK; Klingbeil MA
    Dev Med Child Neurol; 1991 Nov; 33(11):1013-4. PubMed ID: 1743423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of drooling in disabled patients with scopolamine patches.
    Mato A; Limeres J; Tomás I; Muñoz M; Abuín C; Feijoo JF; Diz P
    Br J Clin Pharmacol; 2010 Jun; 69(6):684-8. PubMed ID: 20565460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of drooling using transdermal scopolamine skin patches. A case report.
    Mato Montero A; Limeres Posse J; Tomás Carmona I; Fernández Feijoo J; Diz Dios P
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E27-30. PubMed ID: 18167476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal scopolamine for reduction of drooling in developmentally delayed children.
    Lewis DW; Fontana C; Mehallick LK; Everett Y
    Dev Med Child Neurol; 1994 Jun; 36(6):484-6. PubMed ID: 7516297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal scopolamine use for post-rhytidectomy sialocele.
    Lapid O; Kreiger Y; Sagi A
    Aesthetic Plast Surg; 2004; 28(1):24-8. PubMed ID: 15116278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of transdermal scopolamine to control drooling. A case report.
    Dreyfuss P; Vogel D; Walsh N
    Am J Phys Med Rehabil; 1991 Aug; 70(4):220-2. PubMed ID: 1878183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of salivary flow with Scopoderm TTS.
    Talmi YP; Finkelstein Y; Zohar Y; Laurian N
    Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):128-30. PubMed ID: 3355042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
    Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
    Trials; 2014 Feb; 15():60. PubMed ID: 24533890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital.
    Al Jeraisy M; AlFuraih M; AlSaif R; AlKhalifah B; AlOtaibi H; Abolfotouh MA
    BMC Pediatr; 2020 Sep; 20(1):437. PubMed ID: 32943036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of benztropine therapy for drooling.
    Camp-Bruno JA; Winsberg BG; Green-Parsons AR; Abrams JP
    Dev Med Child Neurol; 1989 Jun; 31(3):309-19. PubMed ID: 2666205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
    Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
    Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of drooling with scopolamine in pediatric ICU: A case series report.
    Franco JB; Cacita N; Freua KA; Ortega KL; de Melo Peres MPS
    Spec Care Dentist; 2018 Nov; 38(6):362-366. PubMed ID: 30238487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopyrrolate for chronic drooling in children.
    Eiland LS
    Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine.
    Ziv I; Versano D; Ruach M; Izraeli S; Almog S; Alhalel A; Alkalay M; Menahem S; Tochner Z
    Br J Clin Pharmacol; 1992 May; 33(5):507-10. PubMed ID: 1524963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transdermal scopolamine on salivation.
    Gordon C; Ben-Aryeh H; Attias J; Szargel R; Gutman D
    J Clin Pharmacol; 1985 Sep; 25(6):407-12. PubMed ID: 4056076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.